Evidence of calpain/cdk5 pathway inhibition by lithium in 3-nitropropionic acid toxicity in vivo and in vitro
Abstract:
Lithium reduced striatal neurodegeneration induced in rats by 3-nitropropionic acid inhibiting calpain activation. Lithium prevented an increase in cdk5 activity, as shown by the levels of the co-activator p35. Myocite enhancer factor 2 (MEF2), a downstream substrate for cdk5 with pro-survival activity, showed increased phosphorylation. In primary cultures of neurons treated with 3-NP, lithium also reduced protease activity mediated by calpain, cdk5 activation and cellular death. These observations indicate that lithium has a neuroprotective effect. Lithium treatment also reduced the intracellular increase in calcium induced by 3-NP. The finding that lithium mediates the modulation of the calpain/cdk5 pathway further supports its use in the treatment of neurodegenerative diseases. © 2008 Elsevier Ltd. All rights reserved.
Año de publicación:
2009
Keywords:
- P35
 - calcium
 - 3-nitropropionic acid
 - Spectrin
 - Lithium
 - Neurodegenerative Disease
 - Calpain
 
Fuente:
scopusTipo de documento:
Article
Estado:
Acceso restringido
Áreas de conocimiento:
- Bioquímica
 - Bioquímica
 
Áreas temáticas de Dewey:
- Farmacología y terapéutica
 - Enfermedades
 
Objetivos de Desarrollo Sostenible:
- ODS 3: Salud y bienestar
 - ODS 12: Producción y consumo responsables
 - ODS 9: Industria, innovación e infraestructura